Just diagnosed with Retinal degeneration-nanophthalmos-glaucoma syndrome?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Retinal degeneration-nanophthalmos-glaucoma syndrome, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Retinal degeneration-nanophthalmos-glaucoma syndrome hub →Overview
Retinal degeneration-nanophthalmos-glaucoma syndrome is a rare condition. Also known as Mackay-Shek-Carr syndrome. Tomeko brings together the specialists, research, clinical trials, treatments and community for Retinal degeneration-nanophthalmos-glaucoma syndrome so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:1574 · OMIM 267760 · ICD-10 H35.5 · GARD 0000395
Find care for Retinal degeneration-nanophthalmos-glaucoma syndrome
Authoritative references for Retinal degeneration-nanophthalmos-glaucoma syndrome
Research & market landscape for Retinal degeneration-nanophthalmos-glaucoma syndrome
Following Retinal degeneration-nanophthalmos-glaucoma syndrome for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Retinal degeneration-nanophthalmos-glaucoma syndrome — the real-world landscape behind the condition, in one place.
- Latest Retinal degeneration-nanophthalmos-glaucoma syndrome research on PubMed ↗
- Recruiting Retinal degeneration-nanophthalmos-glaucoma syndrome trials on ClinicalTrials.gov ↗
- Explore the Retinal degeneration-nanophthalmos-glaucoma syndrome research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Retinal degeneration-nanophthalmos-glaucoma syndrome and every rare condition. See how Tomeko works with industry →
Common questions
What is Retinal degeneration-nanophthalmos-glaucoma syndrome?
Retinal degeneration-nanophthalmos-glaucoma syndrome is a rare condition. Also known as Mackay-Shek-Carr syndrome. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Retinal degeneration-nanophthalmos-glaucoma syndrome together in one place.
What are the symptoms of Retinal degeneration-nanophthalmos-glaucoma syndrome?
Symptoms of Retinal degeneration-nanophthalmos-glaucoma syndrome vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Retinal degeneration-nanophthalmos-glaucoma syndrome.
How is Retinal degeneration-nanophthalmos-glaucoma syndrome treated?
Treatment for Retinal degeneration-nanophthalmos-glaucoma syndrome depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Retinal degeneration-nanophthalmos-glaucoma syndrome, and review current options with them.
What causes Retinal degeneration-nanophthalmos-glaucoma syndrome — is it genetic?
The cause and inheritance of Retinal degeneration-nanophthalmos-glaucoma syndrome are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Retinal degeneration-nanophthalmos-glaucoma syndrome can explain what it means for you and your family.
I was just diagnosed with Retinal degeneration-nanophthalmos-glaucoma syndrome — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Retinal degeneration-nanophthalmos-glaucoma syndrome, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Retinal degeneration-nanophthalmos-glaucoma syndrome?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Retinal degeneration-nanophthalmos-glaucoma syndrome, filtered to your area.
Are there clinical trials for Retinal degeneration-nanophthalmos-glaucoma syndrome?
Tomeko shows live, recruiting studies for Retinal degeneration-nanophthalmos-glaucoma syndrome from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for: